Annexin A1 increases the sensitivity of K562 cell to imatinib

Yaoxue Xuebao

Volumn 48, Issue 6, 2013, Pages 866-873

  Li, Kang Ning ^a   Jin, Jing ^a   Chen, Xiao Guang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

ANXA1; Chronic myelocytic leukemia; Drug resistance; Imatinib

Indexed keywords

BCR ABL PROTEIN; BETA ACTIN; CYCLIN DEPENDENT KINASE 1; IMATINIB; LIPOCORTIN 1; LIPOFECTAMINE; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE; ACTIN; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; DRUG SENSITIVITY; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PROTEIN FAMILY; PROTEIN INTERACTION; WESTERN BLOTTING; DRUG EFFECTS; DRUG RESISTANCE; GENETIC TRANSFECTION; GENETICS; K562 CELL LINE; METABOLISM;

ACTINS; ANNEXIN A1; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; IMATINIB MESYLATE; IMMUNOPRECIPITATION; K562 CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 3; SRC-FAMILY KINASES; TRANSFECTION;

EID: 84882406677     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer [J]. Nat Rev Cancer, 2007, 7:441-453.
2. Kantarjian HM, O'Brien S, Cortes JE, et al. Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis [J]. Cancer, 2003, 97:1033-1041.
3. Cilloni D, Saglio G. CML: a model for targeted therapy [J], Best Pract Res Clin Haematol, 2009, 22:285-294.
4. Roseea PL, Deininger MW. Resistance to imatinib: mutations and beyond [J]. Semin Hematol, 2010, 47:335-343.
5. Shah NP, Nicoll JM, Nagar B, et al. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (ST1571) in chronic phase and blast crisis chronic myeloid leukemia [J]. Cancer Cell, 2002, 2:117-125.
6. Zhu HQ, Liu XL, Li R, et al. Preliminary study of proteins related to blast crisis in chronic myeloid leukemia [J]. Chin J Oncol, 2009, 31:655-659.
7. 2+ signalling to membrane dynamics [J], Nat Rev Mol Cell Biol, 2005, 6:449-461.
8. Rescher U, Gerke V. Annexins-unique membrane binding proteins with diverse functions [J], J Cell Sci, 2004, 117:2631-2639.
9. Lecona E, Barrasa JI, Olmo N, et al. Upregulation of annexin Al expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase [J]. Mol Cell Biol, 2008, 28:4665-4674.
10. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions [J]. Microbiol Mol Biol Rev, 2004, 68:320-344.
11. Huo XF, Zhang JW. Annexinl regulates the erythroid differentiation through ERK signaling pathway [J]. Biochem Biophys Res Commun, 2005, 331:1346-1352.
12. Ubersax JA, Woodbury EL, Quang PN, et al. Targets of the cyclin-dependent kinase Cdkl [J]. Nature, 2003, 425:859-864.
13. Rosengarth A, Gerke V, Luecke H. X-ray structure of fulllength annexin I and implications for membrane aggregation [J], J Mol Biol, 2001, 306:489-498.
14. Lim LHK, Pervaiz S. Annexin I: the new face of an old molecule [J], FASEB J, 2007, 21:968-975.
15. Smythe E, Ayscough KR. Actin regulation in endocytosis [J], J Cell Sci, 2006, 119:4589-4598.
16. Mooren OL, Galletta BJ, Cooper JA. Roles for actin assembly in endocytosis [J], Annu Rev Biochem, 2012, 81:661-686.
17. Futter CE, White IJ. Annexins and endocytosis [J], Traffic, 2007, 8:951-958.
18. McArthur S, Yazid S, Christian H, et al. Annexin Al regulates hormone exocytosis through a mechanism involving actin reorganization [J], FASEB J, 2009, 23:4000-4010.
19. +-ATPase-defective yeast-identification of 6 new end genes [J], J Cell Biol, 1994, 127:373-386.
20. Munn AL, Stevenson BJ, Geli MI, et al. End5, End6, and End7-mutations that cause actin delocalization and block the internalization step of endocytosis in Saccharomyces cerevisiae [J]. Mol Biol Cell, 1995, 6:1721-1742.
21. Raths S, Rohrer J, Crausaz F, et al. end3 and end4: two mutants defective in receptor-mediated endocytosis in Saccharomyces cerevisiae [J]. J Cell Biol, 1993, 120:55-65.
22. Wendland B, McCaffery JM, Xiao Q, et al. A novel fluorescence-activated cell sorter-based screen for yeast endocytosis mutants identifies a yeast homologue of mammalian epsl5 [J]. J Cell Biol, 1996, 135:1485-1500.
23. Ayscough KR, Stryker J, Pokala N, et al. High rates of actin filament turnover in budding yeast and roles for actin in establishment and maintenance of cell polarity revealed using the actin inhibitor latrunculin-A [J], J Cell Biol, 1995, 137:399-416.
24. Kaksonen M, Toret CP, Drubin DG. A modular design for the clathrin-and actin-mediated endocytosis machinery [J], Cell, 2005, 123:305-320.
25. Newpher TM, Smith RP, Lemmon V, et al. In vivo dynamics of clathrin and its adaptor-dependent recruitment to the actinbased endocytic machinery in yeast [J]. Dev Cell, 2005, 9:87-98.
26. Robertson AS, Smythe E, Ayscough KR. Functions of actin in endocytosis [J]. Cell Mol Life Sci, 2009, 66:2049-2065.
27. Samaj J, Baluska F, Voigt B, et al. Endocytosis, actin cytoskeleton, and signaling [J]. Plant Physiol, 2004, 135:1150-1161.
28. Collins A, Warrington A, Taylor KA, et al. Structural organization of the actin cytoskeleton at sites of clathrinmediated endocytosis [J]. Curr Biol, 2011, 21:1167-1175.
29. Römer W, Pontani LL, Sorre B, et al. Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis [J], Cell, 2010, 140:540-553.
30. Taunton J, Rowning BA, Coughlin ML, et al. Actin-dependent propulsion of endosomes and lysosomes by recruitment of N-WASP [J]. J Cell Biol, 2000, 148:519-530.
31. Qualmanna B, Kessels MM, Kelly RB. Molecular links between endocytosis and the actin cytoskeleton [J], J Cell Biol, 2000, 150:111-116.